Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Procept Biorobotics Corp (PRCT)

Procept Biorobotics Corp (PRCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Procept Biorobotics Corp 150 Baytech Drive San Jose CA 95134 USA

www.procept-biorobotics.com P: 650-232-7200

Description:

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. It focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures and sells the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally-invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia. PROCEPT BioRobotics Corporation is based in REDWOOD CITY, Calif.

Key Statistics

Overview:

Market Capitalization, $K 3,501,974
Enterprise Value, $K 3,297,984
Shares Outstanding, K 51,424
Annual Sales, $ 136,190 K
Annual Net Income, $ -105,900 K
Last Quarter Sales, $ 44,540 K
Last Quarter Net Income, $ -25,960 K
EBIT, $ -108,450 K
EBITDA, $ -104,640 K
60-Month Beta 0.95
% of Insider Shareholders 17.40%
% of Institutional Shareholders 89.46%
Float, K 42,476
% Float 82.60%
Short Volume Ratio 0.43

Growth:

1-Year Return 109.60%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.51 on 05/01/24
Latest Earnings Date N/A
Earnings Per Share ttm -2.12
EPS Growth vs. Prev Qtr 5.56%
EPS Growth vs. Prev Year 19.05%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PRCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.34%
Return-on-Assets % -27.91%
Profit Margin % -77.76%
Debt/Equity 0.20
Price/Sales 25.73
Price/Cash Flow N/A
Price/Book 13.27
Book Value/Share 5.14
Interest Coverage -25.48
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar